TME Pharma

TME Pharma's Ordinary Shares

• Date of the IPO: September 28, 2016
• ISIN / Mnemo : NL0015000YE1 / ALTME
• Stock exchange: Euronext Growth Paris
• Fiscal year end : December 31
• Number of shares (March 28, 2025): 94,186,546*
• Liquidity contract: Invest Securities

*Taking into account the shares issuance following the exercise of Warrants Z as published on March 28, 2025.


TME Pharma's Warrants Z

• ISIN NL0015001SR3
• Stock exchange: Euronext Growth Paris
• Number of Warrants Z (March 28, 2025): 2,810,092

 

Rapid access to French brokers

        

Diede van den Ouden has disclosed plans for initial share purchases to become a more significant shareholder in TME Pharma prior to his nomination for appointment as CEO. See his transactions

"I want to commit myself to the success of the company and align my interests with those of other shareholders"

M. Diede van den Ouden a annoncé son intention de procéder à des achats d'actions afin d'augmenter sa participation au capital de TME Pharma en amont de sa nomination au poste de PDG. Voir ses transactions

« Ma démarche s’inscrit dans une volonté forte de contribuer à la réussite de TME Pharma, tout en renforçant l’alignement de mes intérêts avec ceux des autres actionnaires »

Analyst Coverage

Firm  Analyst  Latest Reports (more) 
Invest Securities   Jamila El Bougrini, PhD 2025, Apr 29 (EN/FR)
2025, Feb 07 (EN/FR)
2025, Jan 30 (EN/FR)
In Extenso   Jean-Pierre Loza, PhD  2024, October 29 (EN/FR)
2023, November 06 (EN/FR)
2023, September 25 (EN/FR)
 
TME Pharma N.V. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding TME Pharma’s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of TME Pharma or its management. TME Pharma does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

 

   

 

We use cookies

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (Google Analytics cookies). You can decide for yourself whether you want to accept the cookies. Please note that if you refuse cookies, you may no longer be able to use all of the site's functions.